Interventional Cardiology Devices Market
Interventional Cardiology Devices Market Size, Share & Trends Analysis Report by Product Types (Catheters, PTCA Guidewires, Stents, Balloon Inflation Device, and PTCA Balloons) and by End Users (Hospitals, Cardiac Catheterization Laboratories, Ambulatory Surgical Centers, Cardiac Clinics, and Academic and Research Institutions) Forecast Period (2023-2030)
Interventional cardiology devices market is anticipated to grow at a significant CAGR of 7.1% during the forecast period. Interventional cardiology devices are used in various procedures to diagnose and treat heart conditions. According to WHO, cardiovascular diseases (CVDs) are the leading cause of casualties globally, taking an estimated 17.9 million lives each year. CVDs are a group of disorders of the heart and blood vessels and include coronary heart disease, cerebrovascular disease, rheumatic heart disease, and other conditions. Thus the growth of the market is attributed to factors such as increasing prevalence of CVDs, and advancements in interventional cardiology techniques. Also, to serve rising demand market players have been collaborating to offer enhanced products and services, such activities create a favourable condition for the growth of the market. For instance, in January 2022, GE Healthcare collaborated with Boston Scientific on cardiac care in Southeast Asia. They combine their interventional cardiology portfolios to provide a comprehensive offering ranging from diagnostic to percutaneous coronary intervention (PCI) to cardiac care centers in the region.
Segmental Outlook:
The global interventional cardiology devices market is segmented based on product types and end users. Based on product types, the market is segmented into catheters, PTCA guidewires, stents, balloon inflation devices, and PTCA balloons. Based on end users, the market is categorized into hospitals, cardiac catheterization laboratories, ambulatory surgical centers (ASCs), cardiac clinics, and academic and research institutions. Among product types, stents are expected to hold a prominent market share due to their widespread usage in the treatment of coronary artery diseases.
Hospitals are Expected to Hold a Significant Market Share Over the Forecast Period
Among end-users, hospitals are expected to hold a significant market share over the forecast period. The growth of the sub-segment is attributed to the presence of advanced infrastructure, and availability of skilled healthcare professionals in hospitals across the regions. Moreover, hospitals have high patient footfall leading to increased demand for interventional cardiology devices for performing surgeries and other operations. Further, the expansion of cardiac hospitals across the region is anticipated to propel the growth of the market. For instance, in December 2022, Malaysia's Institute Jantung Negara (IJN) plans to establish new cardiac centers outside Kuala Lumpur, starting with hospitals in Penang and Johor. The expansion aims to accommodate more overseas patients and is expected to begin by 2026.
Regional Outlooks:
The global interventional cardiology devices market is further segmented based on geography, including North America (the US and Canada), Europe (Italy, Spain, Germany, France, and others), Asia-Pacific (India, China, Japan, South Korea, and others), and the Rest of the World (the Middle East & Africa and Latin America). Among these, the European regional market is anticipated to cater to a prominent growth over the forecast period. However, the Asia-Pacific region is projected to experience considerable growth in the interventional cardiology devices market, primarily driven by factors such as the growing prevalence of cardiovascular diseases, improving healthcare infrastructure, and rising healthcare expenditure.
Global Interventional Cardiology Devices Market Growth, by Region 2023-2030
North America is Anticipated to Hold a Significant Share of the Global Interventional Cardiology Devices Market
North America is anticipated to hold a significant share of the global interventional cardiology devices market during the forecast period. According to the Centers for Disease Control and Prevention (CDC), in the US, every 40 seconds, a heart attack occurs. Each year, approximately 805,000 people experience a heart attack. Out of these, 605,000 individuals have their first heart attack, while 200,000 people have a second heart attack. Thus, the widespread prevalence of cardiology related health concerns has been creating a substantial demand for interventional cardiology devices in the region. Additionally, the presence of the leading market players such as Medtronic PLC, Abbott Laboratories, Boston Scientific Corp., Johnson & Johnson, Cardinal Health, Inc., and others have been fostering innovation in the market through the adoption of various strategies to remain competitive in the market. For instance, in April 2022, Medtronic entered an agreement with Acutus Medical to exclusively distribute and acquire its left-heart access portfolio, including trans septal crossing devices. This collaboration aims to strengthen Medtronic's cardiac ablation business strategy and provide advanced technology to support physicians during critical procedures.
Market Players Outlook:
The major companies serving the global interventional cardiology devices market include Boston Scientific Corporation, Medtronic PLC, Abbott Laboratories, Edwards Lifesciences Corp., Edward Lifesciences Corp., Terumo Corp., and B. Braun Melsungen AG., and others. These market players are considerably contributing to market growth through the adoption of various strategies, including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in January 2022, Medtronic plc entered into a definitive agreement to acquire Affera, Inc., a Boston area-based, privately held medical technology company. Affera designs and manufactures cardiac mapping and navigation systems and catheter-based cardiac ablation technologies, including a differentiated, focal pulsed field ablation solution, for the treatment of patients with cardiac arrhythmias (irregular heartbeats) such as atrial fibrillation (AF). The acquisition expands the Medtronic portfolio of advanced cardiac ablation products and accessories to meet physician requirements within a growing patient population.
The Report Covers
- Market value data analysis of 2022 and forecast to 2030.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global interventional cardiology devices market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1. Report Summary
• Current Industry Analysis and Growth Potential Outlook
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Region
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Key Company Analysis
3.2. Abbott Laboratories
3.2.1. Overview
3.2.2. Financial Analysis
3.2.3. SWOT Analysis
3.2.4. Recent Developments
3.3. B. Braun Melsungen AG
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
3.4. Edwards Lifesciences Corp.
3.4.1. Overview
3.4.2. Financial Analysis
3.4.3. SWOT Analysis
3.4.4. Recent Developments
3.5. Medtronic PLC
3.5.1. Overview
3.5.2. Financial Analysis
3.5.3. SWOT Analysis
3.5.4. Recent Developments
3.6. Key Strategy Analysis
4. Market Segmentation
4.1. Global Interventional Cardiology Devices Market by Product Types
4.1.1. Catheters
4.1.2. PTCA Guidewires
4.1.3. Stents
4.1.4. Balloon Inflation Device
4.1.5. PTCA Balloons
4.2. Global Interventional Cardiology Devices Market by End Users
4.2.1. Hospitals
4.2.2. Cardiac Catheterization Laboratories
4.2.3. Ambulatory Surgical Centers (ASCs)
4.2.4. Cardiac Clinics
4.2.5. Academic and Research Institutions
5. Regional Analysis
5.1. North America
5.1.1. United States
5.1.2. Canada
5.2. Europe
5.2.1. UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. South Korea
5.3.5. Rest of Asia-Pacific
5.4. Rest of the World
6. Company Profiles
6.1. Balton Sp. z o.o.
6.2. Biosensor International
6.3. Biotronik SE & Co. KG
6.4. Cardinal Health, Inc.
6.5. Comed B.V.
6.6. Edwards Lifesciences Corp.
6.7. Endocor GmbH
6.8. iVascular S.L.U.
6.9. Johnson & Johnson
6.10. Koninklijke Philips N.V.
6.11. Medinol Ltd.
6.12. Penumbra, Inc.
6.13. Rontis AG
6.14. Scitech
6.15. SMT (Sahajanand Medical Technologies Pvt. Ltd.)
6.16. Stentys SA
6.17. Terumo Corp.
6.18. WELLINQ
1. GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPES, 2022-2030 ($ MILLION)
2. GLOBAL CATHETERS FOR INTERVENTIONAL CARDIOLOGY DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
3. GLOBAL PTCA GUIDEWIRES FOR INTERVENTIONAL CARDIOLOGY DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
4. GLOBAL STENTS FOR INTERVENTIONAL CARDIOLOGY DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
5. GLOBAL BALLOON INFLATION DEVICE FOR INTERVENTIONAL CARDIOLOGY DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
6. GLOBAL PTCA BALLOONS FOR INTERVENTIONAL CARDIOLOGY DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
7. GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES MARKET RESEARCH AND ANALYSIS BY END USERS, 2022-2030 ($ MILLION)
8. GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES FOR HOSPITALS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
9. GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES FOR CARDIAC CATHETERIZATION LABORATORIES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
10. GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES FOR AMBULATORY SURGICAL CENTERS (ASCS) MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
11. GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES FOR CARDIAC CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
12. GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES FOR ACADEMIC AND RESEARCH INSTITUTIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
13. GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
14. NORTH AMERICAN INTERVENTIONAL CARDIOLOGY DEVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
15. NORTH AMERICAN INTERVENTIONAL CARDIOLOGY DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPES, 2022-2030 ($ MILLION)
16. NORTH AMERICAN INTERVENTIONAL CARDIOLOGY DEVICES MARKET RESEARCH AND ANALYSIS BY END USERS, 2022-2030 ($ MILLION)
17. EUROPEAN INTERVENTIONAL CARDIOLOGY DEVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
18. EUROPEAN INTERVENTIONAL CARDIOLOGY DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPES, 2022-2030 ($ MILLION)
19. EUROPEAN INTERVENTIONAL CARDIOLOGY DEVICES MARKET RESEARCH AND ANALYSIS BY END USERS, 2022-2030 ($ MILLION)
20. ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY DEVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
21. ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPES, 2022-2030 ($ MILLION)
22. ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY DEVICES MARKET RESEARCH AND ANALYSIS BY END USERS, 2022-2030 ($ MILLION)
23. REST OF THE WORLD INTERVENTIONAL CARDIOLOGY DEVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
24. REST OF THE WORLD INTERVENTIONAL CARDIOLOGY DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPES, 2022-2030 ($ MILLION)
25. REST OF THE WORLD INTERVENTIONAL CARDIOLOGY DEVICES MARKET RESEARCH AND ANALYSIS BY END USERS, 2022-2030 ($ MILLION)
1. GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES MARKET SHARE BY PRODUCT TYPES, 2022 VS 2030 (%)
2. GLOBAL CATHETERS FOR INTERVENTIONAL CARDIOLOGY DEVICES MARKET SHARE BY REGION, 2022 VS 2030 (%)
3. GLOBAL PTCA GUIDEWIRES FOR INTERVENTIONAL CARDIOLOGY DEVICES MARKET SHARE BY REGION, 2022 VS 2030 (%)
4. GLOBAL STENTS FOR INTERVENTIONAL CARDIOLOGY DEVICES BY MARKET SHARE REGION, 2022 VS 2030 (%)
5. GLOBAL BALLOON INFLATION DEVICE FOR INTERVENTIONAL CARDIOLOGY DEVICES BY MARKET SHARE REGION, 2022 VS 2030 (%)
6. GLOBAL PTCA BALLOONS FOR INTERVENTIONAL CARDIOLOGY DEVICES BY MARKET SHARE REGION, 2022 VS 2030 (%)
7. GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES MARKET SHARE BY END USERS, 2022 VS 2030 (%)
8. GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES FOR HOSPITALS MARKET SHARE BY REGION, 2022 VS 2030 (%)
9. GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES FOR CARDIAC CATHETERIZATION LABORATORIES MARKET SHARE BY REGION, 2022 VS 2030 (%)
10. GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES FOR AMBULATORY SURGICAL CENTERS (ASCS) MARKET SHARE BY REGION, 2022 VS 2030 (%)
11. GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES FOR CARDIAC CLINICS MARKET SHARE BY REGION, 2022 VS 2030 (%)
12. GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES FOR ACADEMIC AND RESEARCH INSTITUTIONS MARKET SHARE BY REGION, 2022 VS 2030 (%)
13. GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES MARKET SHARE BY REGION, 2022 VS 2030 (%)
14. US INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
15. CANADA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
16. UK INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
17. FRANCE INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
18. GERMANY INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
19. ITALY INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
20. SPAIN INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
21. REST OF EUROPE INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
22. INDIA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
23. CHINA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
24. JAPAN INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
25. SOUTH KOREA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
26. REST OF ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
27. REST OF THE WORLD INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
